Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vibhavadi Medical Center PCLBKK:VIBHA-R 70 Days Sales Outstanding is 16.19 as of Mar. 2026, which is 44% below its 10-year median of 28.72. GuruFocus rates BKK:VIBHA-R with a GF Score™ of 70/100 and a GF Value™ of ฿1.65. The stock has 5 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Vibhavadi Medical Center PCL ranks better than 77.47% on this metric.
The historical rank and industry rank for Vibhavadi Medical Center PCL's Days Sales Outstanding or its related term are showing as below:
BKK:VIBHA-R'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 15.62 Med: 28.72 Max: 37.33
Current: 23.39
During the past 13 years, Vibhavadi Medical Center PCL's highest Days Sales Outstanding was 37.33. The lowest was 15.62. And the median was 28.72.
BKK:VIBHA-R's Days Sales Outstanding is ranked better than 77.47% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 47.19
vs BKK:VIBHA-R: 23.39
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vibhavadi Medical Center PCL Days Sales Outstanding Chart
BKK:VIBHA-R vs HCA, THC, DVA: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, Vibhavadi Medical Center PCL's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vibhavadi Medical Center PCL Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vibhavadi Medical Center PCL's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Vibhavadi Medical Center PCL's Days Sales Outstanding falls into.
Vibhavadi Medical Center PCL Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a Days Sales Outstanding of 16.19 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Vibhavadi Medical Center PCL and its competitors. This is 44% below median its historical median of 28.72. Over the past decade, Vibhavadi Medical Center PCL's Days Sales Outstanding has ranged from 15.62 to 37.33. According to the industry distribution chart, Vibhavadi Medical Center PCL ranks #148 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 22.5%.
Is Vibhavadi Medical Center PCL's Days Sales Outstanding too high?
Vibhavadi Medical Center PCL's current Days Sales Outstanding of 16.19 is 44% below median its 10-year median of 28.72. Over the past 10 years, this metric has ranged from a low of 15.62 to a high of 37.33. The Healthcare Providers & Services industry median Days Sales Outstanding is 47.19. Vibhavadi Medical Center PCL's value of 16.19 is 65.7% below this industry median. Based on the distribution chart, Vibhavadi Medical Center PCL ranks #148 out of 657 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Vibhavadi Medical Center PCL has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Vibhavadi Medical Center PCL's Days Sales Outstanding compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Vibhavadi Medical Center PCL ranks #148 out of 657 companies for Days Sales Outstanding. This places Vibhavadi Medical Center PCL in the top 23% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 47.19. Vibhavadi Medical Center PCL's value of 16.19 is 65.7% below this benchmark. Historically, Vibhavadi Medical Center PCL's own Days Sales Outstanding has ranged from 15.62 to 37.33 over the past decade. While the company's 10-year median is 28.72 vs. the industry median of 47.19, Vibhavadi Medical Center PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 47.19, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vibhavadi Medical Center PCL's current Days Sales Outstanding of 16.19 is 65.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Vibhavadi Medical Center PCL and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 47.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vibhavadi Medical Center PCL's current Days Sales Outstanding is 16.19, which is 44% below median its own 10-year median of 28.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibhavadi Medical Center PCL stock overvalued right now?
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a current Days Sales Outstanding of 16.19. The stock's GF Value™ is ฿1.65, compared to a current price of ฿1.36 — trading 17.6% below its estimated fair value. The current Days Sales Outstanding is 16.19, which is 44% below median its 10-year median of 28.72 and 65.7% below the Healthcare Providers & Services industry median of 47.19. Vibhavadi Medical Center PCL's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Vibhavadi Medical Center PCL (BKK:VIBHA-R), the current Days Sales Outstanding is 16.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vibhavadi Medical Center PCL (BKK:VIBHA-R) Overvalued in 2026?
Based on GuruFocus' analysis, Vibhavadi Medical Center PCL stock appears to be undervalued.
The current stock price of ฿1.36 is trading 17.6% below its estimated GF Value™ of ฿1.65.
Key valuation signals for BKK:VIBHA-R:
Days Sales Outstanding: 16.19 (44% below median its 10-year median of 28.72)
GF Value™: ฿1.65 vs. price of ฿1.36 (17.6% below fair value)
Industry Position: 65.7% below the Healthcare Providers & Services median (#148 of 657)
No single metric tells the full story. See the BKK:VIBHA-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vibhavadi Medical Center PCL provides the medical services known as Vibhavadi Hospital. The services provided include Pediatric Diseases, General Surgery, Orthopedic Center, General Medicine, Women's Health, Gastrointestinal Center, Cardiology, Neurology, Brain Tumor Surgery, Gamma Knife Radiosurgery for Brain, Cancer, Respiratory Diseases, Plastic Surgery, ENT (Ear, Nose, Throat) Department, Dental Center, Life Style Health Screening Center, Lasik Center, Eye, Hemodialysis Department, Dermatology Center, and Other Clinics and Services. Its segments include Hospital provides general hospital and hospital in social security; and Others provide rental services and rental space. The majority of the revenue is derived from the Hospital segment.
70GF Score
Get the complete analysis for BKK:VIBHA-R
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIBHA-R has been successfully added to your 
